HCA Healthcare Inc

Latest Results (26.10.2025):

HCA Healthcare Inc reported strong financial results for the second quarter of 2025, showcasing significant growth in revenues, net income, and earnings per share compared to the same period in the previous year. The company also highlighted improvements in adjusted EBITDA and cash flows from operating activities, reflecting robust operational performance and strategic financial management.

Revenue Growth

HCA Healthcare Inc's revenues increased by 6.4% to $18.605 billion in Q2 2025, up from $17.492 billion in Q2 2024, demonstrating solid top-line growth.

Net Income and Earnings Per Share

Net income attributable to HCA Healthcare Inc rose by 13.1% to $1.653 billion. Diluted earnings per share surged by 23.5% to $6.83, with adjusted diluted earnings per share increasing by 24.4% to $6.84.

Adjusted EBITDA and Cash Flow

Adjusted EBITDA grew by 8.4% to $3.849 billion, while cash flows from operating activities more than doubled to $4.210 billion compared to $1.971 billion in Q2 2024.

Operational Highlights

Same facility admissions saw a 1.8% increase, and same facility equivalent admissions rose by 1.7% in Q2 2025. Additionally, same facility revenue per equivalent admission grew by 4.0% year-over-year.

Share Repurchases and Dividend

During Q2 2025, HCA Healthcare Inc repurchased 7.031 million shares of its common stock at a cost of $2.505 billion. The company also declared a quarterly cash dividend of $0.72 per share, payable on September 30, 2025.

2025 Guidance Update

The company updated its 2025 guidance, increasing the revenue range to $74.00-$76.00 billion and net income to $6.11-$6.48 billion. Adjusted EBITDA guidance was also revised upward to $14.70-$15.30 billion, reflecting confidence in continued growth and financial performance.